Glp-1 Analogues Market OverviewThe Glp analogues market size is expected to be worth USD 606.3 billion by 2034.The target market was valued at USD 45.3 billion in 2024.The market is projected to grow ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

Oliver Weber joined Körber on 2 January 2025 as Chief Executive Officer (CEO) Software in the Business Area Pharma. In this role, he will lead the global software business of the Business Area Pharma.

Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery Award winners by category DELIVERY AND DEVICE INNOVATIONSHL Medical for Elexy™ reusable electromechanical ...

Six start-ups bestowed with new ‘heart of pharma’ commendation in recognition of innovations advancing drug delivery and packagingWednesday 22nd January – Live from Porte De Versailles, ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

A well-known fintech executive, Keith brings 33 years of growth-focused software and technology leadership. He previously co-founded Netik and was CEO of Multifonds. Most recently, as Executive ...

In many countries, the social welfare sector is struggling with enormous cost-cutting pressures, labour shortage and the growing demand for its services. VTT Technical Research Centre of Finland, ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Phacilitate, a leading brand that connects advanced therapies industry leaders through inspiring conferences, vibrant communities and market intelligence, today presented Katherine A. High, M.D. with ...

LAVAL, QC / ACCESS Newswire / January 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release fourth quarter and full year 2024 financial results after market close on Wednesday, ...

LAS VEGAS, NV / ACCESS Newswire / January 23, 2025 / Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB:SKVI), an innovative topical and transdermal pharmaceutical research and ...